BIWEEKLY INFUSIONAL 5-FLUOROURACIL (5-FU) AND X-RAYS IN ADVANCED GASTROINTESTINAL CANCER (GICA)

被引：0
|
作者：
BYFIELD, JE
BARONE, R
SEAGREN, S
FRANKEL, S
QUINOL, L
MENDELSOHN, J
机构：
[1] UNIV CALIF SAN DIEGO,DIV RADIAT,LA JOLLA,CA 92037
[2] UNIV CALIF SAN DIEGO,DIV SURG,LA JOLLA,CA 92037
[3] UNIV CALIF SAN DIEGO,DIV MED ONCOL,LA JOLLA,CA 92037
[4] VET ADM HOSP,LA JOLLA,CA 92037
来源：
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH | 1978年 / 19卷 / MAR期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：322 / 322
页数：1
相关论文
共 50 条
  • [41] TREATMENT OF ADVANCED MALIGNANCY WITH 5-FLUOROURACIL (5-FU) COMBINED WITH FOLINIC ACID (FA)
    LOPEZ, AR
    VANTILBURG, A
    BRADLEY, T
    JENSEN, B
    ZIEGLER, J
    ENGELBERG, C
    DEISSEROTH, A
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1984, 25 (MAR): : 178 - 178
  • [42] Severe enterocolitis with capecitabine (CAPE) is not a predictor of gastrointestinal (GI) toxicity with infusional 5-fluorouracil (5-FU)-based regimens: An institutional analysis.
    Parish, Marie
    Cox, Ronald
    Shreenivas, Aditya V.
    Mahipal, Amit
    Chakrabarti, Sakti
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 89 - 89
  • [43] Preoperative chemoradiotherapy with 5-fluorouracil (5-FU) or 5-FU/oxaliplatin (5FU/OX) for rectal cancer is a feasible treatment strategy in the elderly
    Dolinsky, C. M.
    Mahmoud, N. N.
    Mick, R.
    Sun, W.
    Whittington, R.
    Solin, L. J.
    Haller, D. G.
    O'Dwyer, P.
    Fry, R. D.
    Metz, J. M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03): : S308 - S308
  • [44] Selective delivery of 5-fluorouracil (5-FU) to ip tissues using 5-FU microspheres in rats
    Hagiwara, A
    Sakakura, C
    Tsujimoto, H
    Imanishi, T
    Ohgaki, M
    Yamasaki, J
    Sawai, K
    Takahashi, T
    Fujita, T
    Yamamoto, A
    Muranishi, S
    Ikada, Y
    ANTI-CANCER DRUGS, 1997, 8 (02) : 182 - 188
  • [45] ADJUVANT CHEMOTHERAPY WITH 5-FLUOROURACIL (5-FU) OR 5-FU PLUS METHYL-CCNU FOLLOWING SURGERY IN COLONIC CANCER
    DEXEUS, FA
    THIRLWELL, MP
    MACFARLANE, JK
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1978, 19 (MAR): : 367 - 367
  • [46] TOTAL-BODY CLEARANCE OF INFUSIONAL 5-FLUOROURACIL (5FU)
    FLOYD, R
    GRIFFITHS, J
    HORNBECK, C
    FRANKEL, S
    SHARP, T
    BYFIELD, J
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR): : 395 - 395
  • [47] 5-FLUOROURACIL(5-FU) IN PRIMARY TRABECULECTOMY - A RANDOMIZED TRIAL
    LOFTFIELD, K
    BALL, SF
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1991, 32 (04) : 745 - 745
  • [48] ISOLATED LIVER PERFUSION WITH 5-FLUOROURACIL (5-FU) IN MAN
    AIGNER, K
    WALTHER, H
    TONN, JC
    KRAHL, M
    WENZL, A
    MERKER, G
    SCHWEMMLE, K
    CHIRURG, 1982, 53 (09): : 571 - 573
  • [49] EXCRETION OF 5-FLUOROURACIL (5-FU) INTO PANCREATIC-JUICE
    TAKADA, T
    YASUDA, H
    UCHIYAMA, K
    HASEGAWA, H
    GASTROENTEROLOGY, 1993, 104 (04) : A454 - A454
  • [50] TOLERANCE FOR 5-FLUOROURACIL (5-FU) IN RODENTS RECEIVING HYPERALIMENTATION
    SOUCHON, EA
    COPELAND, EM
    WATSON, P
    DUDRICK, SJ
    FEDERATION PROCEEDINGS, 1974, 33 (03) : 692 - 692
12345